Thermo Fisher Scientific Inc.TMONYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-6.1%
5Y CAGR+1.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-6.1%/yr
vs +10.2%/yr prior
5Y CAGR
+1.3%/yr
Recent deceleration
Acceleration
-16.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $8.67B | -13.9% |
| 2024 | $10.07B | +3.3% |
| 2023 | $9.75B | -7.0% |
| 2022 | $10.49B | +12.6% |
| 2021 | $9.32B | +14.6% |
| 2020 | $8.13B | +14.7% |
| 2019 | $7.08B | -0.4% |
| 2018 | $7.12B | +11.0% |
| 2017 | $6.41B | +12.0% |
| 2016 | $5.72B | - |